Clinical trial
A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic…
NCT00403494 · BioMarin Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00403494 |
|---|---|
| Title | A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease |
| Official title | A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease |
| Lead sponsor | BioMarin Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Intermittent Claudication |
| Intervention type | Drug, Other |
| Interventions | Placebo, Sapropterin Dihydrochloride |
| Enrollment | 190 |
| Start date | Dec 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Nov 23, 2006 |
| Last update posted | Jan 7, 2021 |
| Countries | Argentina, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: